Detection of BALF Pathogens and Analysis of Drug Susceptibility in Patients with Bronchiectasis and Infection
Objective:To analyze the pathogenic bacteria distribution and drug susceptibility of bronchoalveolar lavage fluid(BALF)in patients with bronchiectasis(BE)and infection.Method:From May 2020 to May 2022,60 cases of BE patients with infection were selected as the study objects from the Sixth People's Hospital of Fuyang City,and the pathogen detection and drug susceptibility test of BALF samples were performed.Result:Among 60 patients with BE infection,36(60.00%)were positive for BALF culture.A total of 58 strains were isolated,of which 6(10.34%)were Gram-positive,including 3 strains of Staphylococcus aureus,2 strains of Streptococcus pneumoniae and 1 strain of Staphylococcus hemolyticus.There were 50 Gram-negative bacteria strains(86.21%),including 26 strains of Pseudomonas aeruginosa,11 strains of Klebsiella pneumoniae,7 strains of Acinetobacter baumannii,4 strains of Escherichia coli and 2 strains of stenotrophomonas maltophilia,and 2 strains of fungi(3.45%).The resistance rates of Staphylococcus aureus to azithromycin,clindamycin,erythromycin and penicillin were 66.67%,66.67%,66.67%and 100.00%,respectively.Among gram-negative bacteria,Acinetobacter baumannii had the highest drug resistance,among which minocycline and amikacin were the most sensitive(14.29%and 28.57%,respectively),and cefoperazone and sulbactam,piperacillin and tabazotam were 57.14%and 71.43%,respectively.The sensitivity of Pseudomonas aeruginosa to cefoperazone sulbactam,piperacillin tabazotam and amicacin were 19.23%,26.92%and 15.38%,respectively.The sensitivity of Klebsiella pneumoniae to cefoperazone sulbactam,piperacillin tabazotam and amikacin were 18.18%,18.18%and 18.18%,respectively.The sensitivity of Escherichia coli to cefoperazone sulbactam,piperacillin tabazotam and amicacin were 25.00%,25.00%and 25.00%,respectively.Conclusion:The majority of BALF pathogens in BE patients with infection are Gram-negative bacteria,and there are great differences in the sensitivity of various pathogens to antibiotics.Strengthening the monitoring of pathogen resistance is conducive to the clinical formulation or adjustment of the treatment plan of patients.
BronchiectasisInfectionBronchoalveolar lavage fluidPathogen cultureDrug susceptibility test